Raffles Medical's profit rises 0.4% to $71m in FY 2018 | Healthcare Asia Magazine
, Singapore

Raffles Medical's profit rises 0.4% to $71m in FY 2018

This was supported by the 6% revenue growth of the Healthcare Services division.

Raffles Medical Group saw 0.4% YoY profit growth to $71m in FY 2018 from $70.8m in 2017, attributed to higher tax expense, and additional depreciation arising from the recently completed Raffles Specialist Centre.

Revenues also went up by 2.4% YoY to $489.1m from $477.6m. Revenue for Healthcare Services division recorded a revenue increase of 6% whilst the revenue of Hospital Services division decreased marginally by 0.8%.

Revenue from the Hospital Services division in 2018 reduced marginally partly due to the refurbishment of the current inpatient facilities in 2018.

The continued strong operating cashflows generated from the Group’s business operations contributed to a healthy cash position of S$106.0 million. This was after accounting for the distribution of dividend of S$15.6 million and payment of S$101.0 million for investment properties under development as well as capital expenditure for business expansion in the year. 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Dharmais Cancer Hospital leads cancer treatment innovation in Indonesia
CEO Soeko Werdi Nindito Daroekoesoemo unveils advanced technology and seven flagship programmes for cancer treatment.
MakatiMed advances towards precise surgical care with Da Vinci Xi robotic system
The tech allows for minimally invasive techniques in urology, hepatobiliary, cardiovascular, thoracic, obstetrics and gynaecology, and general surgery.